High-density lipoprotein and cardiac glucose metabolism: Implications for management of acute coronary syndromes

Grants

Funding Acknowledgements

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The main article under discussion 2 was supported by the National Heart Foundation (NHF) of Australia, the National Health and Medical Research Council (NHMRC) of Australia, and the Operational Infrastructure Support scheme of the Victorian State Government, Victoria, Australia. CSL provided the rHDL (CSL-111) to the Baker Institute for experimental studies, 2 but provided no funding for this project and had no role in development of the study design, data acquisition, interpretation of data or manuscript preparation.